Comparison of Two Treatments on Nonspecific Neck Pain

NCT ID: NCT06485921

Last Updated: 2024-07-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

48 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-06-01

Study Completion Date

2024-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study was to evaluate the impact of Ischemic Compression (IC) and Instrument Assisted Soft Tissue Mobilization (IASTM) on pain, functionality, cervical range of motion, pressure pain threshold, and quality of life in patients suffering from nonspecific neck pain.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Chronic nonspecific neck pain affects approximately 67% of the global population at least once in their lifetime. This type of neck pain, which is not linked to any specific cause or disease but often associated with the musculoskeletal system, can result from muscle strain or spasms in the neck. It causes functional limitations and decreases quality of life for those affected. Individuals frequently turn to healthcare services and pain-relieving medications in their efforts to manage this discomfort. Chronic nonspecific neck pain is recognized as a significant public health challenge due to its considerable socioeconomic impact. Several studies have indicated that myofascial trigger points in the neck region are associated with nonspecific neck pain and that myofascial trigger point therapy can reduce pain. Therefore, the role of myofascial trigger point therapy in the treatment of nonspecific neck pain has been emphasized in studies.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neck Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Three groups with conventional therapy control group
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Ischemic compression GROUP

This group will receive 90 seconds of ischemic compression on myofascial trigger points in the trapezius, levator scapulae, supraspinatus, infraspinatus, and splenius cervicis, along with exercises and suggestions for workplace modifications.

Group Type ACTIVE_COMPARATOR

Ischemic compression

Intervention Type OTHER

Participants will received a total of 12 treatment sessions over 6 weeks, with 2 sessions per week.

Exercise and workplace modifications

Intervention Type OTHER

Participants will receive stretching and strengthening exercises for neck and scapular stabilizer muscles as a 6-week home program.

Instrument assisted soft tissue mobilization Group

This group will receive 40 seconds of sweeping and 60 seconds of swiveling by instrument-assisted soft tissue mobilization on myofascial trigger points in the trapezius, levator scapulae, supraspinatus, infraspinatus, and splenius cervicis muscles, along with exercises and suggestions for workplace modifications.

Group Type ACTIVE_COMPARATOR

Instrument assisted soft tissue mobilization Group

Intervention Type OTHER

Participants will received a total of 12 treatment sessions over 6 weeks, with 2 sessions per week.

Exercise and workplace modifications

Intervention Type OTHER

Participants will receive stretching and strengthening exercises for neck and scapular stabilizer muscles as a 6-week home program.

Control Group

This group will only receive exercises and suggestions for workplace modifications.

Group Type EXPERIMENTAL

Exercise and workplace modifications

Intervention Type OTHER

Participants will receive stretching and strengthening exercises for neck and scapular stabilizer muscles as a 6-week home program.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ischemic compression

Participants will received a total of 12 treatment sessions over 6 weeks, with 2 sessions per week.

Intervention Type OTHER

Instrument assisted soft tissue mobilization Group

Participants will received a total of 12 treatment sessions over 6 weeks, with 2 sessions per week.

Intervention Type OTHER

Exercise and workplace modifications

Participants will receive stretching and strengthening exercises for neck and scapular stabilizer muscles as a 6-week home program.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Having nonspecific neck pain and at least 3 myofascial trigger points in the back and neck muscles,
2. Pain duration exceeding 3 months,
3. Working with a computer for at least 20 hours per week for at least 1 year,
4. Pain intensity rated as at least 3 on the Visual Analog Scale (VAS),
5. Age between 18 and 50 years

Exclusion Criteria

1. Use of anti-inflammatory, analgesic, anticoagulant, muscle relaxant, or antidepressant medications at the start of the study or within 1 week prior to the study,
2. History of cervical spine surgery or trauma,
3. Neck pain, including inflammatory rheumatic diseases,
4. Malignancy or structural deformity,
5. Coagulation disorders,
6. Presence of cervical radiculopathy or myelopathy,
7. Individuals who have undergone any physical therapy and rehabilitation interventions to the neck and back regions in the last three months
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Istanbul University - Cerrahpasa

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mouna Khosravi

Student

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mouna Khosravi, MSc

Role: PRINCIPAL_INVESTIGATOR

aculty of Health Sciences, Istanbul University-Cerrahpasa, Büyükçekmece/Istanbul, Turkey

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of Health Sciences, Istanbul University-Cerrahpasa

Istanbul, Büyükçekmece, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IstanbulUC-FTR-MK-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.